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Abstract
Background: Over the last two decades, improvements in medical care have been associated with a significant
increase and better outcome of very preterm (VP, < 32 completed gestational weeks) and very low birth weight
(VLBW, < 1500 g) infants. Only a few publications analyse changes of their short-term outcome in a geographically
defined area over more than 10 years. We therefore aimed to investigate the net change of VP- and VLBW infants
leaving the hospital without major complications.
Methods: Our population-based observational cohort study used the Minimal Neonatal Data Set, a database
maintained by the Swiss Society of Neonatology including information of all VP- and VLBW infants. Perinatal
characteristics, mortality and morbidity rates and the survival free of major complications were analysed and their
temporal trends evaluated.
Results: In 1996, 2000, 2004, and 2008, a total number of 3090 infants were enrolled in the Network Database. At
the same time the rate of VP- and VLBW neonates increased significantly from 0.87% in 1996 to 1.10% in 2008 (p <
0.001). The overall mortality remained stable by 13%, but the survival free of major complications increased from
66.9% to 71.7% (p < 0.01). The percentage of infants getting a full course of antenatal corticosteroids increased
from 67.7% in 1996 to 91.4% in 2008 (p < 0.001). Surfactant was given more frequently (24.8% in 1996 compared
to 40.1% in 2008, p < 0.001) and the frequency of mechanical ventilation remained stable by about 43%. However,
the use of CPAP therapy increased considerably from 43% to 73.2% (p < 0.001). Some of the typical neonatal
pathologies like bronchopulmonary dysplasia, necrotising enterocolitis and intraventricular haemorrhage decreased
significantly (p ≤ 0.02) whereas others like patent ductus arteriosus and respiratory distress syndrome increased
(p < 0.001).
Conclusions: Over the 12-year observation period, the number of VP- and VLBW infants increased significantly. An
unchanged overall mortality rate and an increase of survivors free of major complication resulted in a considerable
net gain in infants with potentially good outcome.
Background
Very preterm birth is a major cause of mortality and
morbidity for newborns and imposes a considerable bur-
den on limited health care resources. Over the last two
decades, changes in perinatal management have been
associated with a significant increase and better outcome
of these infants [1,2]. However, the majority of these
reports are based on single centres or neonatal networks
not representing the whole population. In addition data
may be biased by different criteria for referral, admission
or treatment [3]. Only a few publications analyse the
short-term outcome of these infants on a nationwide
basis over more than ten years. On these grounds, the
Swiss data from 1996, 2000, 2004, and 2008 were ana-
lysed, focussing on temporal trends in mortality, morbid-
ity and treatment for VP- and VLBW infants. Special
importance was attached to the short-term survival free
of major complications. Beyond that, temporal changes
in the length of hospital stay as a substitute for the
resources needed were followed. These results were
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finally compared with studies in other countries. Refer-
ring to previous population-based studies, we hypothe-
sised that improvement in obstetric and perinatal
management led to a decrease in mortality resulting in
more survivors with disability.
Methods
The Swiss Neonatal Network & Follow-Up Group, a non-
profit voluntary collaboration of health care professionals
was founded by the Swiss society of Neonatology in 1995
with the goal to improve the quality of neonatal care.
Today, the Network comprises all nine Neonatal Inten-
sive Care Units (NICUs), most of the smaller Neonatal
Units (NUs) and most Neuropediatric Centres caring for
VP and VLBW infants in Switzerland under the auspices
of the Swiss Society of Neonatology. The Network main-
tains a Minimal Neonatal Data Set (MNDS) collecting
anonymous information about the demographics and
outcome of all liveborn infants between 400 and 1500 g
birth weight and/or between 23 0/7 and 31 6/7 gesta-
tional weeks, born at or transferred to a participating
hospital. Data were collected on all infants until death or
discharge home. Mortality rates were calculated for all
infants born alive. Morbidity rates and treatments how-
ever were based only on those infants admitted to a
NICU, and encompass the following diagnoses: intraven-
tricular haemorrhage (IVH), based on the most severe
ultrasound result during the hospital stay using the clas-
sifications defined by Papile et al. [4]; cystic periventricu-
lar leucomalacia (PVL) defined by de Vries et al. [5];
retinopathy of prematurity (ROP) using the international
classification published by the committee for the classifi-
cation of ROP [6]; bronchopulmonary dysplasia (BPD)
defined as an oxygen requirement at 36 weeks gestational
age (GA) according to the NICHD consensus conference
paper [7]; necrotising enterocolitis (NEC) defined as clin-
ical signs (abdominal distension, bilious aspirates and/or
bloody stools) confirmed by radiographically visible intra-
mural gas or at laparotomy (Bell stage 2 and 3) [8]; patent
ductus arteriosus (PDA) which was symptomatic and
required indomethacin or surgery; sepsis with clear clini-
cal, radiological, or histological evidence of infection as
well as at least one microbiologically relevant positive
blood culture. A survival free of major complications was
determined as survival without grade 3 and 4 IVH, cystic
PVL, ROP stage 3 or 4 or BPD. The years 1996, 2000,
2004 and 2008 were chosen because the Swiss Neonatal
Network and Follow-up Group made a special effort to
ensure that data of these years were complete and cor-
rect. To assess the completeness of our data, the number
of infants having been enrolled since 1996 were com-
pared to the birth registry of the Swiss Federal Statistical
Office [9]. Data were collected for 89% of all VLBW
infants in 1996, 90% in 2000, 97% in 2004 and 90% in
2008.
Statistical analysis
A two-sided paired Student’s t-test was performed to
compare mean values of two independent, normally dis-
tributed variables. To determine temporal changes in
the distribution of a variable, the Pearson’s Chi-square
test was used. Probability levels below 0.05 were consid-
ered significant. To determine a temporal trend we used
linear regression models with the coefficient b indicating
the slope of a linear regression line. All statistical ana-
lyses were carried out with R release 2.13.0.
Results
Demographics
According to the Swiss National Registry, there were
83’007 liveborn babies in 1996, 78’458 in 2000, 73’082 in
2004, and 76’691 in 2008. Concurrently the rates of
VLBW infants in Switzerland increased significantly from
0.76% to 0.97% (p96-08 < 0.001, b = 0.06%). 3090 infants
with less than 32 completed gestational weeks and/or with
a birth weight less than 1500 g were included for further
analysis. For the demographic details of the study popula-
tion and their changes over the years see Table 1.
Mortality
Neonatal mortality rate
412 (13.3%) infants died during the study period, 96 (3.1%)
of which in the delivery room. We observed 292 (9.4%)
early neonatal (perinatal) deaths, defined as a death of a
live born child within the first 7 days of life. A late neona-
tal death, occurring after 7 but before 28 completed days
was found in 81 (2.6%) cases. The sum of early and late
neonatal deaths amounted to an average of 12.1%. The
rates for early-, late-, and neonatal deaths did not change
significantly during the 12 years of observation.
Survival analysis
The survival rate was 86.8% in 1996, 84.1% in 2000,
86.7% in 2004, 88.2% in 2008, and on average 86.5%.
The increase from 1996 to 2008 was not significant (p96-
08 = 0.22, b = 0.70%) even though the Kaplan-Meier
analysis (Figure 1) showed an overall better survival in
2008 resulting from considerably higher survival rates
during the first 48 days of life. The mean duration till
death amounted to 13.4 days in 1996, 12.7 days in 2000,
7.0 days in 2004 and 7.5 days in 2008. During the whole
study period only a trend towards a lower mean dura-
tion till death was found (p96-08 = 0.09, b = -2.3 days).
Gestational age
When stratifying the study population according to the
GA we could observe significant lower mortality rates in
2008 for the two youngest GA groups (< 26 weeks of
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Table 1 Demographic changes of the study population from 1996 to 2008
Year 1996-2008 1996 2000 2004 2008
Characteristics No. (%) p-value 1996-2000 No. (%) p-value 2000-2004 No. (%) p-value 2004-2008 No. (%) p-value 1996-2008
Very preterm infants1 2665 (86.2) 606 (84.2) 0.07 674 (87.1) 0.24 662 (87.8) 0.04 723 (85.9) 0.23
Very low birth weight infants2 425 (13.8) 114 (15.8) 0.03 100 (12.9) 0.57 92 (12.2) 0.09 119 (14.1) 0.18
Small for gestational age3 576 (18.6) 146 (20.3) 0.06 136 (17.6) 0.90 134 (17.8) 0.36 460 (19.0) 0.35
Gender
- female 1507 (48.8) 342 (47.5) 0.11 390 (50.4) 0.22 363 (48.1) 0.65 412 (48.9) 0.41
- male 1583 (51.2) 378 (52.5) 384 (49.6) 391 (51.9) 430 (51.1)
Location of birth
- inborn4 2806 (90.8) 622 (86.4) 0.07 686 (88.6) < 0.001 711 (94.3) 0.30 787 (93.5) < 0.001
- outborn 284 (9.2) 98 (13.6) 88 (11.4) 43 (5.7) 55 (6.5)
Mode of delivery5
- spontaneous 567 (18.3) 174 (24.2) < 0.001 143 (18.5) 0.24 127 (16.8) 0.09 123 (14.6) < 0.001
- caesarean section 2395 (77.5) 521 (72.4) < 0.01 595 (76.9) < 0.01 610 (80.9) 0.29 669 (79.5) < 0.001
Number of infants
- singleton 2144 (69.4) 541 (75.1) < 0.01 546 (70.5) 0.13 513 (68.0) 0.03 544 (64.6) < 0.001
- multiples 946 (30.6) 179 (24.9) 228 (29.5) 241 (32.0) 298 (35.4)
Characteristics p0.5 (p0.05-p0.95) Mean p-value 1996-2000 Mean p-value 2000-2004 Mean p-value 2004-2008 Mean p-value 1996-2008
Gestational age (week) 30 0/7 (25 0/7 - 33 5/7) 29 6/7 < 0.01 29 3/7 1 29 3/7 0.35 29 4/7 0.04
Birth weight (g) 1225 (630 - 1840) 1238 0.13 1209 0.56 1220 0.51 1208 0.11
p0.5 = 50th percentile = median, p0.05 = 5th percentile, p0.95 = 95th percentile, 1 infants born < 32 weeks of gestation, 2 infants born ≥32 weeks of gestation with a birth weight < 1500 g, 3 birth weight < 10th
percentile, 4 born in one of the nine perinatal centres, 5 cephalic forceps and cephalic ventouse deliveries were not listed separately
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gestation: p96-08 = 0.02, and 26-27 weeks of gestation:
p96-08 = 0.04). For the two older GA groups the differ-
ence between 1996 and 2008 was not statistically signifi-
cant (p-values > 0.05). Infants with < 26 completed
gestational weeks had a seven times higher relative risk
(RR) to die than those who were at least 26 completed
gestational weeks old (RR = 6.8). A detailed analysis of
survival regarding gender, mode of delivery, location of
birth, number of infants, GA and birth weight is given
in Table 2.
Morbidity
The incidence of typical neonatal morbidities and their
temporal trends are given in Table 3. This table also
analyses these morbidities in combination with other
variables, such as gender, birth weight, GA, location of
birth, and mode of delivery.
Neonatal outcome
The overall survival free of major complications was
68.6%. 66.9% in 1996, 68.0% in 2000, 67.5% in 2004 and
71.7% in 2008, reflecting a significant improvement in
the short-term outcome over time (p96-08 < 0.01, b =
1.4%). The age-stratified survival free of major complica-
tion is evident from Figure 2.
Length of stay
The mean length of stay (LOS) was based upon the survi-
vors only and amounted to 59.7 days in 1996, 58.5 days
in 2000, 55.0 days in 2004 and 60.1 days in 2008. For the
overall study period, an average in-hospital stay of 58.4
days was calculated (p96-00 = 0.81, p00-04 = 0.17, p04-08 <
0.01, p96-08 = 0.81, b = -0.2 days). The GA was inversely
correlated with the LOS and reached up to 108 days for
infants < 26 weeks i.e. 21, 42 and 63 days longer than for
infants born between 26-27, 28-29 and 30-31 completed
gestational weeks respectively. Between 1996 and 2008
we found a significant increase in the LOS for infants
born < 26 gestational weeks (p96-08 = 0.01, b = 4.3 days)
as well as a significant decrease for infants born between
26-27 gestational weeks (p96-08 = 0.04, b = -2.9 days).
The age stratified LOS are shown in Figure 3. Male
infants and singletons were significantly longer hospita-
lised than females and multiples (59.6 vs. 57.1 days, p =
0.047 and 60.2 vs. 54.4 days, p < 0.001). Over the twelve
years of observation, there were no significant changes in
the LOS regarding gender, number of infants, mode of
delivery, and location of birth (all p96-08 > 0.05).
Therapies
Information about administration of antenatal steroids,
surfactant treatment and oxygen therapy are presented
in Table 4.
CPAP treatment
Continuous positive airway pressure (CPAP) was given
to 63.6% of the included infants namely 43.0% in 1996,
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Figure 1 Kaplan-Meier survival curve per year.
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Table 2 Analysis of survival
Year 1996-2008 1996 2000 2004 2008
Characteristics No. (%) p-value 1. -
2.
relative
risk
No. (%) p-value 96 -
00
No. (%) p-value 00 -
04
No. (%) p-value 04 -
08
No. (%) p-value 96 -
08
Overall mortality rate 412 (13.3) 95
(13.2)
0.04 122
(15.8)
0.04 98
(13.0)
0.20 97
(11.5)
0.15
Mortality rate by gender
1. females 177 (11.7) 0.55 1 41
(12.0)
0.26 54 (13.8) 0.07 38
(10.5)
0.91 44
(10.7)
0.41
2. males 235 (14.8) 1.13 54
(14.3)
0.06 68 (17.7) 0.22 60
(15.3)
0.09 53
(12.3)
0.24
Mortality rate by mode of
delivery1
1. spontaneous 107 (18.9) 0.17 1.65 33
(19.0)
0.70 29 (20.3) 0.54 23
(18.1)
0.95 22
(17.9)
0.75
2. caesarean section 273 (11.4) 1 58
(11.1)
< 0.01 86 (14.5) 0.03 70
(11.5)
0.03 59 (8.8) 0.06
Mortality rate by location of birth
1. inborn2 376 (13.4) 0.89 1.06 81
(13.0)
0.01 112
(16.3)
0.02 92
(12.9)
0.26 91
(11.6)
0.23
2. outborn 36 (12.7) 1 14
(14.3)
0.43 10 (11.4) 0.60 6 (14.0) 0.51 6 (10.9) 0.47
Mortality rate by number of
infants
1. singleton 308 (14.4) 0.50 1.31 75
(13.9)
0.17 87 (15.9) 0.30 73
(14.2)
0.60 73
(13.4)
0.75
2. multiples 104 (11.0) 1 20
(11.2)
0.05 35 (15.4) 0.03 25
(10.4)
0.18 24 (8.1) 0.09
Mortality rate by gestational age3
< 26 186 (56.0) 6.8a 40
(58.8)
0.26 60 (64.5) 0.05 45
(54.2)
0.15 41
(46.6)
0.02
26-27 115 (23.1) 4.7a 25
(26.0)
0.95 34 (25.8) 0.51 30
(23.3)
0.17 26
(18.4)
0.04
28-29 52 (7.5) 2.0a 14 (8.2) 0.69 13 (7.4) 0.83 12 (7.0) 0.92 13 (7.3) 0.50
30-31 46 (4.0) 1.3a 11 (4.0) 0.78 10 (3.7) 0.68 9 (3.2) 0.77 16 (5.0) 0.32
Characteristics p0.5 (p0.05-p0.95) p-value 1. - 2. mean p-value 96 -
00
Mean p-value 00 -
04
mean p-value 04 -
08
mean p-value 96 -
08
Birth weight (g)
1. survivors 1225 (630-1840) < 0.001 1283 0.49 1279 0.94 1264 0.05 1244 0.01
2. deaths 795 (480-1625) 943 0.02 835 0.11 918 0.79 935 0.89
Gestational age (week)
1. survivors 30 0/7 (25 0/7 - 33 5/
7)
< 0.001 30 2/7 0.56 30 0/7 0.96 29 6/7 0.02 29 6/7 < 0.01
2. deaths 26 3/7 (23 6/7 - 31 5/
7)
27 2/7 0.10 26 5/7 0.90 26 5/7 0.32 27 0/7 0.52
p0.5 = 50th percentile = median, p0.05 = 5th percentile, p0.95 = 95th percentile, 1cephalic forceps and cephalic ventouse deliveries were not listed separately, 2 inborn = born in one oft the nine perinatal centres, 3
children born > 32 completed gestational weeks were not listed separately, a relative to the older age groups
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60.7% in 2000, 75.8% in 2004 and 73.2% in 2008, result-
ing in a significant increase of 70.4% between 1996 and
2008 (p96-08 < 0.001, b = 10.6%). Most of the newborns
who had to be treated with CPAP were those with a GA
between 26-27 weeks namely 79.8%, whereas the figures
for infants born > 26, 28-29, and 30-31 completed gesta-
tional weeks accounted for 65.4%, 76.8% and 60.4%
respectively. All GA groups showed a significant shift
towards a more frequent use of CPAP therapy (all p96-08
< 0.001, b < 26 GA = 13.0%, b26-27 GA = 8.4%, b28-29 GA =
11.5%, b30-31GA = 12.4%). This change could most
impressively be documented in the age group of infants
born between 30-31 gestational weeks. With 36.2% in
1996 and 71.2% in 2008 the incidence of CPAP therapy
nearly doubled. There was no difference in the use of
CPAP regarding gender (females vs. males, p = 0.78),
number of infants (singletons vs. multiples, p = 0.70),
mode of delivery (spontaneous vs. caesarean section, p =
0.60) and location of birth (inborn vs. outborn, p =
0.38), but again, the same significant increase of CPAP
treatment was found when analysing all four variables
separately over time. The overall mean duration of
CPAP administration was 9.7 days taking into account
the surviving infants only. The respective figures were
3.9 days in 1996, 8.2 days in 2000, 12.8 days in 2004
and 13.8 days in 2008, which is equal to a 3.4 days’
increase every four years (p96-00 < 0.001, p00-04 < 0.001,
p04-08 = 0.36, p96-08 < 0.001). The cumulative percentage
of survivors per year treated with CPAP can be seen in
Figure 4.
Mechanical ventilation
The frequency of infants who were mechanically venti-
lated was 45.0% in 1996, 39.6% in 2000, 41.8% in 2004
and 45.6% in 2008, which corresponded to an average
rate of 43.0%. Altogether we found significant changes
between 1996 and 2000 and between 2004 and 2008
(p96-00 < 0.01, p00-04 = 0.23, p04-08 = 0.03, p96-08 = 0.74).
Mechanical ventilation was inversely correlated with
GA: 84.2% of the infants with < 26 completed gesta-
tional weeks, 71.2% of those with 26-27 weeks, 51.4% of
those with 28-29 weeks and 28.0% of those with 30-31
weeks were ventilated. We found only one significant
difference towards a less frequent use of mechanical
ventilation regarding infants born < 26 completed
Table 3 Incidence of neonatal morbidities and their temporal trends over the years
BPDa No.
(%)
NECb No.
(%)
IVHc No.
(%)
PVLd No.
(%)
PDAe No.
(%)
RDSf No.
(%)
ROPg No.
(%)
Sepsis No.
(%)
1996 - 20081 (n =
2983)
470 (15.7) 76 (2.5) 176 (5.9) 66 (2.2) 584 (19.6) 2428 (81.4) 38 (1.2) 291 (9.8)
19961 (n = 702) 125 (17.8) 23 (3.3) 43 (6.1) 12 (1.7) 105 (15.0) 550 (78.3) 13 (1.9) 60 (8.5)
20001 (n = 750) 104 (13.9) 22 (2.9) 51 (6.8) 18 (2.4) 128 (17.1) 584 (77.9) 4 (0.5) 81 (10.8)
20041 (n = 728) 123 (16.9) 17 (2.3) 49 (6.7) 21 (2.9) 148 (20.3) 615 (84.5) 9 (1.2) 65 (8.9)
20081 (n = 803) 118 (14.7) 14 (1.7) 33 (4.1) 15 (1.9) 203 (25.3) 679 (84.6) 12 (1.5) 85 (10.6)
p-value 1996-2008 0.02 0.01 0.02 0.71 < 0.001 < 0.001 0.40 0.03
Gender
- female 217 (14.8) 42 (2.9) 75 (5.1) 39 (2.7) 300 (20.5) 1156 (79.1) 14 (1.0) 130 (8.9)
- male 251 (16.5) 34 (2.2) 100 (6.6) 27 (1.8) 284 (18.7) 1272 (83.6) 22 (1.4) 161 (10.6)
Location of birth
- inborn2 417 (15.5) 65 (2.3) 149 (5.5) 59 (2.2) 529 (19.6) 2205 (81.7) 30 (1.1) 267 (9.9)
- outborn 51 (18.0) 11 (3.9) 26 (9.2) 7 (2.5) 55 (19.4) 223 (78.5) 6 (2.1) 24 (8.5)
Mode of delivery3
- spontaneous 100 (19.0) 11 (2.1) 42 (8.0) 10 (1.9) 105 (19.9) 428 (81.2) 13 (2.5) 51 (9.7)
- caesarean section 353 (15.0) 63 (2.7) 118 (5.0) 53 (2.3) 450 (19.2) 1914 (81.5) 21 (0.9) 234 (10.0)
Number of infants
- singleton 365 (17.7) 59 (2.9) 129 (6.2) 53 (2.6) 426 (20.6) 1715 (83.1) 32 (1.5) 216 (10.5)
- multiples 103 (11.2) 17 (1.9) 46 (5.0) 13 (1.4) 158 (17.2) 713 (77.7) 4 (0.4) 75 (8.2)
Gestational age4
< 26 103 (38.7) 16 (6.0) 46 (17.3) 10 (3.8) 111 (41.7) 249 (93.6) 20 (7.5) 55 (20.7)
26-27 180 (37.0) 17 (3.5) 59 (12.1) 13 (2.7) 183 (37.7) 466 (95.9) 9 (1.9) 98 (20.2)
28-29 123 (18.0) 18 (2.6) 48 (7.0) 16 (2.3) 160 (23.4) 624 (91.1) 6 (0.9) 80 (11.7)
30-31 50 (4.4) 18 (1.6) 21 (1.9) 22 (2.0) 113 (10.0) 889 (79.0) 1 (0.1) 42 (3.7)
1 infants who died in the delivery room were excluded, 2 born in one of the nine perinatal centres, 3 cephalic forceps and cephalic ventouse deliveries were not
listed separately, 4 children born > 32 completed gestational weeks were not listed separately, a bronchopulmonary dysplasia, b necrotising enterocolitis, c
intraventricular haemorrhage grade III or IV, d cystic periventricular leucomalacia, e patent ductus arteriosus, f respiratory distress syndrome, g retinopathy of
prematurity grade 3 or 4
Rüegger et al. BMC Pediatrics 2012, 12:17
http://www.biomedcentral.com/1471-2431/12/17
Page 6 of 12
gestational weeks (p96-08 = 0.045). However there was no
difference concerning mechanical ventilation regarding
gender (females vs. males, p = 0.50), number of infants
(singletons vs. multiples, p = 0.29), mode of delivery
(spontaneous vs. caesarean section, p = 0.81), and loca-
tion of birth (inborn vs. outborn, p = 0.30). The overall
mean duration of mechanical ventilation was 3.6 days
when taking into account the surviving infants only.
With 3.5 days in 1996, 3.1 days in 2000, 3.7 days in
2004 and 4.1 days in 2008 the changes from one obser-
vation period to the other as well as over the whole
length of the study were not significant (all p-values >
0.05).
Discussion
Our study shows a considerable net gain in VP- and
VLBW infants discharged home without major compli-
cations in a stable population over 12 years. This
added value is composed of three factors: 1) Increase
of the absolute (122) and relative (16.9%) number of
VP- and VLBW infants, stable overall mortality rate
and higher rate of survivors without major complica-
tions (absolute increase 122, relative 25.3%). This find-
ing was not expected and differs in various aspects
from previously published results. We will discuss
methodological issues and compare the results with
those of other studies for the four main topics, popula-
tion characteristics, mortality, in-hospital morbidity
and therapies. Comparison of such global population
based trends must be considered with caution as inclu-
sion criteria, definitions of referral, morbidities, treat-
ments, and discharge policies may vary.
Obstetrics/delivery/birth characteristics
Obstetric management changed with respect to the per-
centage of mothers who were treated with antenatal cor-
ticosteroids as well as with respect to the mode of
delivery. This trend probably reflects the improved
chance of survival these infants now have, justifying the
greater risk to which the mother is exposed to when
undergoing surgery compared to natural childbirth. The
number of outborn infants decreased significantly,
p-value p-value p-value p-value regression
GA (weeks) 96-00 00-04 04-08 96-08 coeff. β
<26 <0.001 0.07 0.20 <0.01 1.6%
26-27 <0.001 0.12 0.13 <0.001 3.3%
28-29 0.03 0.16 0.04 <0.01 2.5%
30-31 0.59 0.17 0.75 0.05 1.2%
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reflecting an on-going trend to centralise high-risk preg-
nancies in perinatal centres. As a matter of fact, this cor-
responds to findings of different studies showing that
infants who were born in NICUs had lower mortality
rates than infants who were transported extrauterinely
[10,11]. As expected, the increasing rates of VP- and
VLBW infants in our study population correlated with
the mean GA but surprisingly not with the mean birth
weight. However the surviving infants were both younger
and lighter in 2008 than in 1996. The factors underlying
these findings are thought to be improvements in obste-
tric care and a rise in obstetric interventions during preg-
nancy [12]. With 18.6%, our percentage of small for
gestational age infants was much lower compared to
those of other studies. Zeitlin et al. for example reported
rates between 32.9 and 35.5% based on the EPIPAGE and
MOSAIC cohort including VP infants between 1997 and
2003 [13]. This difference was inexplicable as our study
population consisted not only of VP- but also of VLBW
infants resulting in more infants with birth weights under
the 10th percentile.
Mortality
The overall mortality rate of our study population
remained stable over time on an average of 13.3%.
Excluding the VLBW infants, a mortality rate of 15.0%
was found. Both rates are similar to those reported by
other European studies [13-15]. When focussing on our
group of infants with < 26 and with 26-27 weeks of GA
the mortality rate decreased significantly over time as
shown in Table 2. This decline might predominantly be
attributable to significant increases of both the adminis-
tration of antenatal steroids as well as the use of surfac-
tant treatment, resulting in a better survival of the
youngest infants. These results were additionally influ-
enced by the publication of the Swiss guidelines on the
care of infants born at the limit of viability in 2002,
which were likewise followed by a significantly improved
survival of extremely preterm infants [16].
Horbar and the members of the Vermont Oxford net-
work discussed potential explanations for the levelling
off in the overall mortality during the last two decades
[17]: They hypothesised that firstly an inappropriate use
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of some interventions, such as either an overuse of
interventions for infants unlikely to benefit from them,
an underuse of potentially beneficial interventions, or a
misuse of interventions by inexperienced or unskilled
personnel may have resulted in adverse events and sec-
ondly, that health professionals as well as families have
become more cautious in extending and continuing
intensive care treatments for extremely preterm infants.
The third argument of the authors, namely having
reached the limits of current technology to support pre-
term infants at gestational ages near the limits of viabi-
lity, might not be applicable to Switzerland, as recent
data show better survival of these infants [18,19].
Extending this study by children born in 2012, as we
plan to do, may confirm this finding.
Morbidity
Regarding the results of other studies examining the rela-
tion between antenatal steroids and respiratory distress
syndrome (RDS) [20], we expected to find a decrease in
the incidence of RDS, which however, increased signifi-
cantly by 8% to 84.6%. Ersch et al. demonstrated similar
findings in their survey of a geographically limited neona-
tal population [21]. They found that the incidence of RDS
in infants admitted to neonatal units doubled over the
last 30 years, which was ascribed to the corresponding
increase in the rate of caesarean section. We suggest that
in our cohort, the above-mentioned constant mortality
rate given, the severity of RDS must have been reduced
by the increasing antenatal treatment with corticoster-
oids. The rising survival of the most immature infants
and the infants with RDS did not result in an increased
number of infants with BPD, which was unexpected and
quite contrary to other reports, where an increased survi-
val resulted in more morbidity, mainly BPD [22-24].
In spite of better detection techniques and more ultra-
sound examinations being routinely made nowadays, the
incidence of serious IVH decreased and the rate of cystic
PVL remained stable. Again, there might be a positive influ-
ence of antenatal corticosteroids on the incidence of IVH
and PVL as was shown in the previously mentioned meta-
analysis by Crowley [20]. The diagnosis of a patent arterial
duct (PDA) was made more frequently over time. This is
most likely due to an intensified diagnostic workup, espe-
cially by systematic echocardiographs in VP- and VLBW
infants. The incidence of necrotising enterocolitis (NEC)
decreased significantly to 1.7% mainly due to the preventive
administration of probiotics in Switzerland since 2006 [25].
Table 4 Treatment of the liveborns
supplemental oxygen No. (%) surfactant No. (%) antenatal steroids No. (%)
1996-20081 1933 (64.8) 972 (32.6) 2311 (77.5)
19961 472 (67.2) 174 (24.8) 475 (67.7)
20001 489 (65.2) 221 (29.5) 508 (67.7)
20041 492 (67.6) 255 (35.0) 594 (81.6)
20081 480 (59.8) 322 (40.1) 734 (91.4)
p-value 1996-2008 < 0.001 < 0.001 < 0.001
No. (%) p-value No. (%) p-value No. (%) p-value
Gender
- female 922 (63.1) 0.77 435 (29.8) 0.50 1132 (77.4) 0.99
- male 1011 (66.5) 537 (35.3) 1179 (77.5)
Location of birth
- inborn2 1728 (64.0) 0.48 865 (32.0) 0.49 2144 (79.4) 0.08
- outborn 205 (72.2) 107 (37.7) 167 (58.8)
Mode of delivery3
- spontaneous 327 (62.0) 0.76 141 (26.8) 0.38 392 (74.4) 0.71
- caesarean section 1537 (65.5) 789 (33.6) 1852 (78.9)
Number of infants
- singleton 1387 (67.2) 0.49 722 (35.0) 0.49 1525 (73.8) 0.35
- multiples 546 (59.5) 250 (27.2) 786 (85.6)
Gestational age4
< 26 234 (88.0) 167 (62.8) 201 (75.6)
26-27 435 (89.5) 286 (58.8) 377 (77.6)
28-29 534 (78.0) 261 (38.1) 536 (78.2)
30-31 234 (20.8) 234 (20.8) 903 (80.3)
1 infants who died in the delivery room were excluded, 2 born in one of the nine perinatal centres, 3 cephalic forceps and cephalic ventouse deliveries were not
listed separately, 4 children born > 32 completed gestational weeks were not listed separately
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The survival free of major complications which repre-
sents besides mortality the most crucial variable defining
neonatal outcome, significantly increased. This finding is
remarkable as it was neither adversely affected by an
increasing number of VP infants nor by better survival
rates of the youngest GA groups. Zeitlin et al. investigated
the short-term outcome of live births before 32 weeks of
gestation in 10 European regions and found large differ-
ences in neurologic and respiratory morbidity despite
similar standards of living and healthcare provision [26].
They reported rates between 71.2 and 89.7% for a survival
without IVH/PVL or BPD raising questions about variabil-
ity in treatment decisions and population characteristics.
Fanaroff et al. defined a survival without major neonatal
morbidity as survival without IVH, NEC, and BPD and
found a stable rate of 70% between 1995 and 2002 regard-
ing VLBW infants only [23]. Despite stricter criteria
including the absence of IVH, cystic PVL, BPD, and ROP,
our results are similar to those of other European and
American groups.
Therapies
The increasing antenatal application of corticosteroids
as well as the wide use of rescue surfactant therapy led
to a change in respiratory support strategy towards
early use of nasal CPAP starting in the delivery room
and reducing thereby the need for intubation in pre-
term babies [27,28]. In our study the increased use of
antenatal corticosteroids was not associated with a
decreased use of surfactant. That was unexpected and
could most likely be explained by additional indications
for surfactant administration, namely early administra-
tion in the delivery room based on risk not on severity
of RDS.
We additionally documented an impressive 70%
increase in the use of CPAP as well as a far longer dura-
tion of CPAP therapy by approximately 10 days between
1996 and 2008. Despite this, the use of mechanical ven-
tilation did not change in terms of period and number
of ventilated infants. Taken together, we think that the
increasing rates of antenatal corticosteroid- and postna-
tal surfactant administration, the decreasing use of sup-
plemental oxygen as well as lung-protective ventilation
strategies are among the most important factors to
explain our lower BPD rate in 2008. This rate of 14.7%
is similar to those reported in the two population-based
cohort studies EPIPAGE in 1997 (14.4.%) and MOSAIC
in 2003 (15.3%) [13].
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Strengths and limitations of the study
Strengths of our study are 1) Prospective definition of
inclusion criteria and specific morbidities remaining
unchanged over the whole observation period. 2) The
recruitment of subjects based on a homogenous, geogra-
phically defined population. 3) An observation period of
12-years, 4) a special effort to enhance data quality by
on-site visits and matching with the official population
statistics, and 5) presenting temporal trends not only of
mortality and morbidity but also of therapies used in a
large sample of VP- and VLBW infants.
Our study is limited by the lack of information about
the long-term outcome of our infants. However, there is
an association between major complications and neuro-
developmental outcome. This data is currently being
collected and will be reported later.
Conclusions
Over the 12-year observation period, the number of VP-
and VLBW infants increased significantly. An unchanged
overall mortality rate and an increase of survivors free of
major complication resulted in a considerable net gain in
infants with potentially good outcome. This improved
short-term outcome was associated with a shorter hospital
stay and therefore less cost. Follow-up of this cohort will
show whether this benefit will persist.
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